Drug interactions in Brazilian type 2 diabetes patients

The aim of this paper is to identify the prevalence of the most frequent drug interactions in patients using oral antidiabéticos and their association with capillary glucose and medication adherence. In total, 579 type 2 diabetes mellitus patients from 12 health institutions in Fortaleza, Brazil wer...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of nursing practice 2013-08, Vol.19 (4), p.423-430
Hauptverfasser: de Araújo, Márcio Flávio Moura, dos Santos Alves, Priscila de Jesus, Veras, Vivian Saraiva, de Araújo, Thiago Moura, Zanetti, Maria Lúcia, Damasceno, Marta Maria Coelho
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 430
container_issue 4
container_start_page 423
container_title International journal of nursing practice
container_volume 19
creator de Araújo, Márcio Flávio Moura
dos Santos Alves, Priscila de Jesus
Veras, Vivian Saraiva
de Araújo, Thiago Moura
Zanetti, Maria Lúcia
Damasceno, Marta Maria Coelho
description The aim of this paper is to identify the prevalence of the most frequent drug interactions in patients using oral antidiabéticos and their association with capillary glucose and medication adherence. In total, 579 type 2 diabetes mellitus patients from 12 health institutions in Fortaleza, Brazil were interviewed in 2009. A form was applied, including questions on medication use, comorbidities, lifestyle, body mass index and random capillary glucose. Results revealed that 26.7% used five or more different drugs simultaneously and daily. Statistically significant drug interactions occurred between antidiabéticos and diuretics, angiotensin‐converting enzyme inhibitors, anti‐lipidaemics and corticoids. No significant association was found between polypharmacy, medication adherence and glucose. It is important for nurses, in consensus with other health professionals, to consider the possibility of other drugs that mean less risk for diabetes patients’ glucose control or of increased antidiabetics doses.
doi_str_mv 10.1111/ijn.12078
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1431009263</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1431009263</sourcerecordid><originalsourceid>FETCH-LOGICAL-i4188-56bce01ec40626610aa4da8f0227a9b69548e69722c57e1521d8402326e3e72d3</originalsourceid><addsrcrecordid>eNqNkU1P5DAMhiME4vuwfwBV4rKXgu2kSXtcWL6_hACB9hJlWoMy2-kMTSsYfj2BAQ6c8CV2_Ly2kleIXwhbGGPbD5stJDD5nFhGpSBFQ3fzMZdEqUFUS2IlhCFAvMBsUSyRLDBTSMvC_G37h8Q3Hbeu7Py4CbFIdlr34mvvmqSbTjihpPJuwB2HZOI6z00X1sTCvasDr3-cq-Jmf-969zA9vTg42v1zmnqFeZ5melAyIJcKNGmN4JyqXH4PRMYVA11kKmddGKIyM4wZYZUrIEmaJRuq5Kr4PZs7acePPYfOjnwoua5dw-M-WFQSAQrS8icoYF6Axh-gmEttQENEN7-hw3HfNvHNkSKVSZTF2-6ND6ofjLiyk9aPXDu1nx8dge0Z8ORrnn71EeybgzY6aN8dtEfH5-9JVKQzhQ8dP38pXPvfaiNNZm_PD-y_S7N_dbJzZq_kK3EvmBU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1424531393</pqid></control><display><type>article</type><title>Drug interactions in Brazilian type 2 diabetes patients</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>de Araújo, Márcio Flávio Moura ; dos Santos Alves, Priscila de Jesus ; Veras, Vivian Saraiva ; de Araújo, Thiago Moura ; Zanetti, Maria Lúcia ; Damasceno, Marta Maria Coelho</creator><creatorcontrib>de Araújo, Márcio Flávio Moura ; dos Santos Alves, Priscila de Jesus ; Veras, Vivian Saraiva ; de Araújo, Thiago Moura ; Zanetti, Maria Lúcia ; Damasceno, Marta Maria Coelho</creatorcontrib><description>The aim of this paper is to identify the prevalence of the most frequent drug interactions in patients using oral antidiabéticos and their association with capillary glucose and medication adherence. In total, 579 type 2 diabetes mellitus patients from 12 health institutions in Fortaleza, Brazil were interviewed in 2009. A form was applied, including questions on medication use, comorbidities, lifestyle, body mass index and random capillary glucose. Results revealed that 26.7% used five or more different drugs simultaneously and daily. Statistically significant drug interactions occurred between antidiabéticos and diuretics, angiotensin‐converting enzyme inhibitors, anti‐lipidaemics and corticoids. No significant association was found between polypharmacy, medication adherence and glucose. It is important for nurses, in consensus with other health professionals, to consider the possibility of other drugs that mean less risk for diabetes patients’ glucose control or of increased antidiabetics doses.</description><identifier>ISSN: 1322-7114</identifier><identifier>EISSN: 1440-172X</identifier><identifier>DOI: 10.1111/ijn.12078</identifier><identifier>PMID: 23915412</identifier><language>eng</language><publisher>Australia: Blackwell Publishing Ltd</publisher><subject>Adherence ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; antihypertensives ; Brazil ; Comorbidity ; Cross-Sectional Studies ; Diabetes ; Diabetes Mellitus, Type 2 - drug therapy ; Diabetics ; Drug Interactions ; Drugs ; Female ; Glucose ; Humans ; hypoglycaemics ; Hypoglycemic Agents - pharmacology ; Hypoglycemic Agents - therapeutic use ; Male ; Middle Aged ; Nursing ; Patient Compliance ; Patients ; Pharmacology ; Prevalence ; Type 2 diabetes mellitus</subject><ispartof>International journal of nursing practice, 2013-08, Vol.19 (4), p.423-430</ispartof><rights>2013 Wiley Publishing Asia Pty Ltd</rights><rights>2013 Wiley Publishing Asia Pty Ltd.</rights><rights>Copyright Blackwell Publishing Ltd. Aug 2013</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fijn.12078$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fijn.12078$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,30976,30977,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23915412$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>de Araújo, Márcio Flávio Moura</creatorcontrib><creatorcontrib>dos Santos Alves, Priscila de Jesus</creatorcontrib><creatorcontrib>Veras, Vivian Saraiva</creatorcontrib><creatorcontrib>de Araújo, Thiago Moura</creatorcontrib><creatorcontrib>Zanetti, Maria Lúcia</creatorcontrib><creatorcontrib>Damasceno, Marta Maria Coelho</creatorcontrib><title>Drug interactions in Brazilian type 2 diabetes patients</title><title>International journal of nursing practice</title><addtitle>Int J Nurs Pract</addtitle><description>The aim of this paper is to identify the prevalence of the most frequent drug interactions in patients using oral antidiabéticos and their association with capillary glucose and medication adherence. In total, 579 type 2 diabetes mellitus patients from 12 health institutions in Fortaleza, Brazil were interviewed in 2009. A form was applied, including questions on medication use, comorbidities, lifestyle, body mass index and random capillary glucose. Results revealed that 26.7% used five or more different drugs simultaneously and daily. Statistically significant drug interactions occurred between antidiabéticos and diuretics, angiotensin‐converting enzyme inhibitors, anti‐lipidaemics and corticoids. No significant association was found between polypharmacy, medication adherence and glucose. It is important for nurses, in consensus with other health professionals, to consider the possibility of other drugs that mean less risk for diabetes patients’ glucose control or of increased antidiabetics doses.</description><subject>Adherence</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>antihypertensives</subject><subject>Brazil</subject><subject>Comorbidity</subject><subject>Cross-Sectional Studies</subject><subject>Diabetes</subject><subject>Diabetes Mellitus, Type 2 - drug therapy</subject><subject>Diabetics</subject><subject>Drug Interactions</subject><subject>Drugs</subject><subject>Female</subject><subject>Glucose</subject><subject>Humans</subject><subject>hypoglycaemics</subject><subject>Hypoglycemic Agents - pharmacology</subject><subject>Hypoglycemic Agents - therapeutic use</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nursing</subject><subject>Patient Compliance</subject><subject>Patients</subject><subject>Pharmacology</subject><subject>Prevalence</subject><subject>Type 2 diabetes mellitus</subject><issn>1322-7114</issn><issn>1440-172X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqNkU1P5DAMhiME4vuwfwBV4rKXgu2kSXtcWL6_hACB9hJlWoMy2-kMTSsYfj2BAQ6c8CV2_Ly2kleIXwhbGGPbD5stJDD5nFhGpSBFQ3fzMZdEqUFUS2IlhCFAvMBsUSyRLDBTSMvC_G37h8Q3Hbeu7Py4CbFIdlr34mvvmqSbTjihpPJuwB2HZOI6z00X1sTCvasDr3-cq-Jmf-969zA9vTg42v1zmnqFeZ5melAyIJcKNGmN4JyqXH4PRMYVA11kKmddGKIyM4wZYZUrIEmaJRuq5Kr4PZs7acePPYfOjnwoua5dw-M-WFQSAQrS8icoYF6Axh-gmEttQENEN7-hw3HfNvHNkSKVSZTF2-6ND6ofjLiyk9aPXDu1nx8dge0Z8ORrnn71EeybgzY6aN8dtEfH5-9JVKQzhQ8dP38pXPvfaiNNZm_PD-y_S7N_dbJzZq_kK3EvmBU</recordid><startdate>201308</startdate><enddate>201308</enddate><creator>de Araújo, Márcio Flávio Moura</creator><creator>dos Santos Alves, Priscila de Jesus</creator><creator>Veras, Vivian Saraiva</creator><creator>de Araújo, Thiago Moura</creator><creator>Zanetti, Maria Lúcia</creator><creator>Damasceno, Marta Maria Coelho</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QJ</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201308</creationdate><title>Drug interactions in Brazilian type 2 diabetes patients</title><author>de Araújo, Márcio Flávio Moura ; dos Santos Alves, Priscila de Jesus ; Veras, Vivian Saraiva ; de Araújo, Thiago Moura ; Zanetti, Maria Lúcia ; Damasceno, Marta Maria Coelho</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-i4188-56bce01ec40626610aa4da8f0227a9b69548e69722c57e1521d8402326e3e72d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adherence</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>antihypertensives</topic><topic>Brazil</topic><topic>Comorbidity</topic><topic>Cross-Sectional Studies</topic><topic>Diabetes</topic><topic>Diabetes Mellitus, Type 2 - drug therapy</topic><topic>Diabetics</topic><topic>Drug Interactions</topic><topic>Drugs</topic><topic>Female</topic><topic>Glucose</topic><topic>Humans</topic><topic>hypoglycaemics</topic><topic>Hypoglycemic Agents - pharmacology</topic><topic>Hypoglycemic Agents - therapeutic use</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nursing</topic><topic>Patient Compliance</topic><topic>Patients</topic><topic>Pharmacology</topic><topic>Prevalence</topic><topic>Type 2 diabetes mellitus</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>de Araújo, Márcio Flávio Moura</creatorcontrib><creatorcontrib>dos Santos Alves, Priscila de Jesus</creatorcontrib><creatorcontrib>Veras, Vivian Saraiva</creatorcontrib><creatorcontrib>de Araújo, Thiago Moura</creatorcontrib><creatorcontrib>Zanetti, Maria Lúcia</creatorcontrib><creatorcontrib>Damasceno, Marta Maria Coelho</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of nursing practice</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>de Araújo, Márcio Flávio Moura</au><au>dos Santos Alves, Priscila de Jesus</au><au>Veras, Vivian Saraiva</au><au>de Araújo, Thiago Moura</au><au>Zanetti, Maria Lúcia</au><au>Damasceno, Marta Maria Coelho</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Drug interactions in Brazilian type 2 diabetes patients</atitle><jtitle>International journal of nursing practice</jtitle><addtitle>Int J Nurs Pract</addtitle><date>2013-08</date><risdate>2013</risdate><volume>19</volume><issue>4</issue><spage>423</spage><epage>430</epage><pages>423-430</pages><issn>1322-7114</issn><eissn>1440-172X</eissn><abstract>The aim of this paper is to identify the prevalence of the most frequent drug interactions in patients using oral antidiabéticos and their association with capillary glucose and medication adherence. In total, 579 type 2 diabetes mellitus patients from 12 health institutions in Fortaleza, Brazil were interviewed in 2009. A form was applied, including questions on medication use, comorbidities, lifestyle, body mass index and random capillary glucose. Results revealed that 26.7% used five or more different drugs simultaneously and daily. Statistically significant drug interactions occurred between antidiabéticos and diuretics, angiotensin‐converting enzyme inhibitors, anti‐lipidaemics and corticoids. No significant association was found between polypharmacy, medication adherence and glucose. It is important for nurses, in consensus with other health professionals, to consider the possibility of other drugs that mean less risk for diabetes patients’ glucose control or of increased antidiabetics doses.</abstract><cop>Australia</cop><pub>Blackwell Publishing Ltd</pub><pmid>23915412</pmid><doi>10.1111/ijn.12078</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1322-7114
ispartof International journal of nursing practice, 2013-08, Vol.19 (4), p.423-430
issn 1322-7114
1440-172X
language eng
recordid cdi_proquest_miscellaneous_1431009263
source Applied Social Sciences Index & Abstracts (ASSIA); MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Adherence
Adolescent
Adult
Aged
Aged, 80 and over
antihypertensives
Brazil
Comorbidity
Cross-Sectional Studies
Diabetes
Diabetes Mellitus, Type 2 - drug therapy
Diabetics
Drug Interactions
Drugs
Female
Glucose
Humans
hypoglycaemics
Hypoglycemic Agents - pharmacology
Hypoglycemic Agents - therapeutic use
Male
Middle Aged
Nursing
Patient Compliance
Patients
Pharmacology
Prevalence
Type 2 diabetes mellitus
title Drug interactions in Brazilian type 2 diabetes patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T20%3A16%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Drug%20interactions%20in%20Brazilian%20type%202%20diabetes%20patients&rft.jtitle=International%20journal%20of%20nursing%20practice&rft.au=de%20Ara%C3%BAjo,%20M%C3%A1rcio%20Fl%C3%A1vio%20Moura&rft.date=2013-08&rft.volume=19&rft.issue=4&rft.spage=423&rft.epage=430&rft.pages=423-430&rft.issn=1322-7114&rft.eissn=1440-172X&rft_id=info:doi/10.1111/ijn.12078&rft_dat=%3Cproquest_pubme%3E1431009263%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1424531393&rft_id=info:pmid/23915412&rfr_iscdi=true